These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22301371)

  • 1. Cognitive function in health and disease: the role of epigenetic mechanisms.
    Mungenast AE; Tsai LH
    Neurodegener Dis; 2012; 10(1-4):191-4. PubMed ID: 22301371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring Tip60 HAT/HDAC2 Balance in the Neurodegenerative Brain Relieves Epigenetic Transcriptional Repression and Reinstates Cognition.
    Panikker P; Xu SJ; Zhang H; Sarthi J; Beaver M; Sheth A; Akhter S; Elefant F
    J Neurosci; 2018 May; 38(19):4569-4583. PubMed ID: 29654189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylases in memory and cognition.
    Penney J; Tsai LH
    Sci Signal; 2014 Dec; 7(355):re12. PubMed ID: 25492968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of HDAC inhibitors as cognitive enhancers.
    Gräff J; Tsai LH
    Annu Rev Pharmacol Toxicol; 2013; 53():311-30. PubMed ID: 23294310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the correct HDAC(s) to treat cognitive disorders.
    Fischer A; Sananbenesi F; Mungenast A; Tsai LH
    Trends Pharmacol Sci; 2010 Dec; 31(12):605-17. PubMed ID: 20980063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
    Konsoula Z; Barile FA
    J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylase 2 Inhibition Attenuates Downregulation of Hippocampal Plasticity Gene Expression during Aging.
    Singh P; Thakur MK
    Mol Neurobiol; 2018 Mar; 55(3):2432-2442. PubMed ID: 28364391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epigenetic blockade of cognitive functions in the neurodegenerating brain.
    Gräff J; Rei D; Guan JS; Wang WY; Seo J; Hennig KM; Nieland TJ; Fass DM; Kao PF; Kahn M; Su SC; Samiei A; Joseph N; Haggarty SJ; Delalle I; Tsai LH
    Nature; 2012 Feb; 483(7388):222-6. PubMed ID: 22388814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone acetylation: molecular mnemonics on the chromatin.
    Gräff J; Tsai LH
    Nat Rev Neurosci; 2013 Feb; 14(2):97-111. PubMed ID: 23324667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders.
    Gediya P; Parikh PK; Vyas VK; Ghate MD
    Eur J Med Chem; 2021 Apr; 216():113332. PubMed ID: 33714914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Deacetylases 1 and 2 Regulate Microglia Function during Development, Homeostasis, and Neurodegeneration in a Context-Dependent Manner.
    Datta M; Staszewski O; Raschi E; Frosch M; Hagemeyer N; Tay TL; Blank T; Kreutzfeldt M; Merkler D; Ziegler-Waldkirch S; Matthias P; Meyer-Luehmann M; Prinz M
    Immunity; 2018 Mar; 48(3):514-529.e6. PubMed ID: 29548672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase in neuropathology.
    Gupta R; Ambasta RK; Kumar P
    Adv Clin Chem; 2021; 104():151-231. PubMed ID: 34462055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons.
    Yamakawa H; Cheng J; Penney J; Gao F; Rueda R; Wang J; Yamakawa S; Kritskiy O; Gjoneska E; Tsai LH
    Cell Rep; 2017 Aug; 20(6):1319-1334. PubMed ID: 28793257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications as novel therapeutic targets for Huntington's disease.
    Wang F; Fischhaber PL; Guo C; Tang TS
    Epigenomics; 2014 Jun; 6(3):287-97. PubMed ID: 25111483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of histone acetylation in SMN gene expression.
    Kernochan LE; Russo ML; Woodling NS; Huynh TN; Avila AM; Fischbeck KH; Sumner CJ
    Hum Mol Genet; 2005 May; 14(9):1171-82. PubMed ID: 15772088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.
    de la Fuente Revenga M; Ibi D; Saunders JM; Cuddy T; Ijaz MK; Toneatti R; Kurita M; Holloway T; Shen L; Seto J; Dozmorov MG; González-Maeso J
    Neuroscience; 2018 Sep; 388():102-117. PubMed ID: 30025863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modifications in the nervous system and their impact upon cognitive impairments.
    Rudenko A; Tsai LH
    Neuropharmacology; 2014 May; 80():70-82. PubMed ID: 24495398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
    Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration.
    Ganai SA; Ramadoss M; Mahadevan V
    Curr Neuropharmacol; 2016; 14(1):55-71. PubMed ID: 26487502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis.
    Turgeon N; Gagné JM; Blais M; Gendron FP; Boudreau F; Asselin C
    Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G594-605. PubMed ID: 24525021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.